이상반응 보고
VAERS ID | 1158667 |
---|---|
성별 | 알 수 없음 |
나이 | |
주 코드 | |
제약회사 | JANSSEN |
로트 번호 | |
예방접종 횟수 | |
접종일 | |
발병일 | 2021-03-09 |
상태 |
증상
- 모유를 통한 노출(Exposure via breast milk)
이환 중 질병
지병
Comments: Unknown
기타 의료
이전 예방접종
알레르기
임상 검사
증상 상세
BREASTFEEDING EXPOSURE; This spontaneous report received from a pharmacist concerned a patient of unspecified age and sex.
The patient's weight, height, and medical history were not reported.
The patient received covid-19 vaccine ad26.
cov2.
s (suspension for injection, transmammary, batch number: Unknown) dose was not reported, administered on 09-MAR-2021 for prophylactic vaccination.
The batch number was not reported and has been requested.
No concomitant medications were reported.
On 09-MAR-2021, the patient experienced breastfeeding exposure.
The reporter was not informed that the mother of the patient was lactating, The reporter received a call on 10-Mar-2021 and was informed that the mother of the patient is breastfeeding and would like to know if she could continue breastfeeding after getting vaccinated.
No side effect were reported The action taken with covid-19 vaccine ad26.
cov2.
s was not applicable.
The outcome of breastfeeding exposure was not reported.
The reporter considered the causality between covid-19 vaccine ad26.
cov2.
s, and breastfeeding exposure as related.
Company causality between covid-19 vaccine ad26.
cov2.
s, and breastfeeding exposure was possible.
This report was serious (Other Medically Important Condition).
; Sender's Comments: 20210320488-covid-19 vaccine ad26.
cov2.
s-Breast feeding exposure.
This event(s) is considered not related.
The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility.
There are other factors more likely to be associated with the event(s) than the drug.
Specifically: SPECIAL SITUATIONS